By Kevin Stawicki ( December 3, 2019, 10:02 PM EST) -- The Ninth Circuit ruled Tuesday that Takeda Pharmaceuticals Co. and Eli Lilly & Co. must face claims that they concealed links between bladder cancer and their diabetes drug Actos, saying the proposed class of patients and purchasers can seek damages because they sufficiently alleged the companies' omissions harmed them....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.